TILT Biotherapeutics (private company)

See something wrong or missing? Let us know
Offices:
Helsinki
Business model:
B2B
Key People:
Akseli Hemminki
Investors:
we tracked 2 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

TILT Biotherapeutics Ltd is a preclinical stage company working in the field of cancer immunotherapy. TILT aims to translate its unique approach into clinical trials.

The company’s patented technology involves utilization of oncolytic viruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR) and checkpoint inhibiting antibody therapy.

The TILT approach has the potential to achieve similar results in CAR therapy of  solid tumors as currently achieved for CD19+ hematological tumors.

Companies with similar profile to TILT Biotherapeutics:

CompanyCriteria
Finland Synoste Oy
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Lifeline Ventures
  • At least one other investor: Business Finland
  • Total raised in a similar range: 10M+ USD
Finland Oura Health
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Lifeline Ventures
  • At least one other investor: Business Finland
  • Total raised in a similar range: 10M+ USD
Finland Valkee
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Lifeline Ventures
  • Total raised in a similar range: 10M+ USD
Denmark Galecto Biotech
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland TrademarkNow
44%
  • Similar business models: B2B
  • At least one vc investor: Lifeline Ventures
  • At least one other investor: Business Finland
  • Total raised in a similar range: 5M - 10M USD
Finland Iceye
44%
  • Similar business models: B2B
  • At least one vc investor: Lifeline Ventures
  • At least one other investor: Business Finland
  • Total raised in a similar range: 10M+ USD
Iceland Alvotech
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland Varjo
44%
  • Similar business models: B2B
  • At least one vc investor: Lifeline Ventures
  • At least one other investor: Business Finland
  • Total raised in a similar range: 10M+ USD
Sweden Monocl
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Finland Norsepower
44%
  • Similar business models: B2B
  • At least one vc investor: Lifeline Ventures
  • At least one other investor: Business Finland
  • Total raised in a similar range: 5M - 10M USD
Sweden Gradientech
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 5M - 10M USD
Finland Nanoform Finland
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Cavidi
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Finland Mobidiag
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Aprea Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden ITBMed
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD